Femtech companies grow despite the digital health downturn: Women’s health startups are garnering investor attention in a post-Roe America. We explore how they can build on the momentum and reach more female patients.
Cigna partners with Virgin Pulse: Cigna members will get a personalized health and wellness platform to record their health journeys. But without real incentives, we’re skeptical it’ll see long-term engagement.
Big Pharma’s drug prices in the crosshairs: A new report from AARP shows the list prices for the top 25 Medicare Part D drugs grew ~226% since they were launched. It’s down to the wire in the feud over Medicare prescription drug price negotiations.
We’re seeing record bankruptcies among VC-backed startups. Factors include rate hikes, investment shortages, and bank collapses. AI funding rises, but potential oversaturation looms.
Generative AI isn’t a strategy by itself: But healthcare execs should start nailing down their AI priorities soon, before the next wave of AI tools breaks over their heads.
Digital health startups to watch: We spotlight kidney health management company Healthmap and at-home medical exam platform TytoCare on the back of fresh funding.
Healthcare, pharma digital ad spending slowdown impacts Doximity: The company recognizes that its digital marketing solutions strategy must shift to meet its customers’ needs.
Remote monitoring for heart failure patients: Geisinger and Bodyport are expanding a program to non-invasively measure fluid levels and other biometrics on a daily basis. It’s an advance on conventional weight scales.
Patients are digital health believers: Healthcare providers are actively responding to consumer demands for better technology. They’ll need to keep it going, or risk losing patients to competitors.
Employers are worried about covering GLP-1s for weight loss: Prescriptions written for obesity drugs are skyrocketing. We examine Teladoc’s plan to rein in the costs for employers.
Connected fitness users are pulling the plug: Our updated forecast shows US adults are heading back to the gym or outdoor fitness routines, leaving Peloton, Mirror, and others behind.
The Mark Cuban Cost Plus Drug juggernaut keeps rolling: Now that it’s turned to the self-insured employer market, the low-cost drug company is making deals to expand its operations and offerings. Here’s the latest.
Digital health startups to watch: We spotlight clinical AI company RapidAI and Indonesian-based telehealth startup Halodoc on the back of fresh funding.
Can drone delivery take off in healthcare? Health systems and pharmacies are starting to use the technology to deliver medications and supplies. We unpack the pros and cons.
Search engine vs. chatbot: Researchers asked Google and ChatGPT for answers to questions that patients with dementia and their caregivers would ask when looking for medical information online. The results weren’t surprising.
Amazon doubles down on D2C healthcare: Amazon Clinic now offers video telehealth visits in all 50 states, adding to its previous text-messaging services. But will consumers trust the Big Tech giant with their personal health data?
Signify Health adds in-home kidney health evaluations: We explore how its expanded services dovetail with CVS’ other healthcare businesses.
Hims & Hers’ new offering combines sexual health and heart health: Preventative care services via a single-pill therapy could increase Hims and Hers’ already impressive retention rates.
The cost of a data breach keeps rising: For the 13th year in a row, healthcare ranks No. 1 for costliest data breaches, and pharma isn't far behind. The time to invest in AI and automation tools is now.
GoodRx debuts in-app medication management features: Medication adherence apps are a dime a dozen. But GoodRx is hoping its rewards system will keep consumers around.